Charles Theuer - 12 Dec 2025 Form 4 Insider Report for 4D Molecular Therapeutics, Inc. (FDMT)

Role
Director
Signature
/s/ Scott Bizily as Attorney-in-Fact for Charles Theuer
Issuer symbol
FDMT
Transactions as of
12 Dec 2025
Net transactions value
+$10,640
Form type
4
Filing time
16 Dec 2025, 16:35:36 UTC
Previous filing
20 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
THEUER CHARLES Director C/O 4D MOLECULAR THERAPEUTICS, INC., 5858 HORTON STREET #455, EMERYVILLE /s/ Scott Bizily as Attorney-in-Fact for Charles Theuer 16 Dec 2025 0001631338

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FDMT Common Stock Options Exercise $10,640 +9,333 +29% $1.14 41,684 12 Dec 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FDMT Stock Option (Right to Buy) Options Exercise $0 -9,333 -100% $0.000000 0 12 Dec 2025 Common Stock 9,333 $1.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested.